Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 4,026 | 5,226 | 5,772 | 6,752 | 9,820 |
| Operating Income | -4,026 | -5,226 | -5,772 | -6,752 | -9,820 |
| Interest Expense | 175 | 232 | 273 | 253 | 222 |
| Other Income | 56 | 388 | 286 | -216 | 1,810 |
| Pre-tax Income | -4,145 | -5,070 | -5,759 | -7,221 | -8,232 |
| Income Tax | 3 | -1 | 8 | 4 | -3 |
| Net Income Continuous | -4,148 | -5,069 | -5,767 | -7,225 | -8,229 |
| Minority Interests | -51 | -15 | N/A | N/A | N/A |
| Net Income | $-4,097 | $-5,054 | $-5,767 | $-7,225 | $-8,229 |
| EPS Basic Total Ops | 13.17 | -7.75 | -16.75 | -24.37 | 69.87 |
| EPS Basic Continuous Ops | 11.86 | -7.77 | -12.99 | -24.40 | 69.51 |
| EPS Diluted Total Ops | 13.17 | -7.75 | -16.75 | -24.37 | 69.87 |
| EPS Diluted Continuous Ops | 11.86 | -7.77 | -12.99 | -24.40 | 69.51 |
| EPS Diluted Before Non-Recurring Items | N/A | -7.80 | -16.81 | -24.01 | N/A |
| EBITDA(a) | $-3,629 | $-4,827 | $-5,378 | $-6,362 | $-9,735 |